FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384296306> ?p ?o ?g. }

• W4384296306 abstract "Background Cerebral small vessel disease (CSVD) is common in the elderly population. Neutrophil gelatinase-associated lipocalin (NGAL) is closely related to cardiovascular and cerebrovascular diseases. NGAL causes pathological changes, such as damage to the vascular endothelium, by causing inflammation, which results in other related diseases. The purpose of this study was to investigate whether serum NGAL levels could predict disease severity in patients with CSVD. Methods The patients with CSVD who visited the Department of Neurology at the First Affiliated Hospital of Zhengzhou University between January 2018 and June 2022 were prospectively included. The total CSVD burden score was calculated using whole-brain magnetic resonance imaging (MRI), and the patients were divided into a mild group (total CSVD burden score &lt; 2 points) and a severe group (total CSVD burden score ≥ 2 points). Age, sex, height, smoking and alcohol consumption history, medical history, and serological results of patients were collected to perform the univariate analysis. Multivariate logistic regression was used to analyze the risk factors that affect CSVD severity. The multiple linear regression method was used to analyze which individual CSVD markers (periventricular white matter hyperintensities, deep white matter hyperintensities, lacune, and cerebral microbleed) play a role in the association between total CSVD burden score and NGAL. Results A total of 427 patients with CSVD (140 in the mild group and 287 in the severe group) were included in the study. A multivariate logistic regression analysis showed that the following factors were significantly associated with CSVD severity: male sex [odds ratio(OR), 1.912; 95% confidence interval (CI), 1.150–3.179], age (OR, 1.046; 95% CI, 1.022–1.070), history of cerebrovascular disease (OR, 3.050; 95% CI, 1.764–5.274), serum NGAL level (OR, 1.005; 95% CI, 1.002–1.008), and diabetes (OR, 2.593; 95% CI, 1.424–4.722). A multivariate linear regression shows that periventricular white matter hyperintensities and cerebral microbleed are associated with serum NGAL concentrations ( P &lt; 0.05). Conclusion Serum NGAL level is closely related to CSVD severity and is a risk factor for the burden of CSVD brain damage. Serum NGAL has high specificity in reflecting the severity of CSVD." @default.
• W4384296306 created "2023-07-15" @default.
• W4384296306 creator A5007277206 @default.
• W4384296306 creator A5015560996 @default.
• W4384296306 creator A5017582962 @default.
• W4384296306 creator A5024027469 @default.
• W4384296306 creator A5033229269 @default.
• W4384296306 creator A5037045116 @default.
• W4384296306 creator A5040166982 @default.
• W4384296306 creator A5040171201 @default.
• W4384296306 creator A5047283512 @default.
• W4384296306 creator A5064840609 @default.
• W4384296306 creator A5069425289 @default.
• W4384296306 creator A5076799260 @default.
• W4384296306 creator A5081754547 @default.
• W4384296306 date "2023-07-14" @default.
• W4384296306 modified "2023-09-28" @default.
• W4384296306 title "Correlation between neutrophil gelatinase phase lipocalin and cerebral small vessel disease" @default.
• W4384296306 cites W109374319 @default.
• W4384296306 cites W1588950918 @default.
• W4384296306 cites W1971029155 @default.
• W4384296306 cites W1981984722 @default.
• W4384296306 cites W2012342018 @default.
• W4384296306 cites W2026909977 @default.
• W4384296306 cites W2030827970 @default.
• W4384296306 cites W2034141105 @default.
• W4384296306 cites W2052055930 @default.
• W4384296306 cites W2052204033 @default.
• W4384296306 cites W2082432121 @default.
• W4384296306 cites W2091931051 @default.
• W4384296306 cites W2104901197 @default.
• W4384296306 cites W2109128578 @default.
• W4384296306 cites W2115017507 @default.
• W4384296306 cites W2115390024 @default.
• W4384296306 cites W2128139323 @default.
• W4384296306 cites W2140621953 @default.
• W4384296306 cites W2144034260 @default.
• W4384296306 cites W2150553293 @default.
• W4384296306 cites W2151306562 @default.
• W4384296306 cites W2151960299 @default.
• W4384296306 cites W2157032372 @default.
• W4384296306 cites W2158742097 @default.
• W4384296306 cites W2159899308 @default.
• W4384296306 cites W2166609052 @default.
• W4384296306 cites W2289667985 @default.
• W4384296306 cites W2527017317 @default.
• W4384296306 cites W2565609152 @default.
• W4384296306 cites W2613917013 @default.
• W4384296306 cites W2622183425 @default.
• W4384296306 cites W2759050422 @default.
• W4384296306 cites W2765167648 @default.
• W4384296306 cites W2791999005 @default.
• W4384296306 cites W2800682109 @default.
• W4384296306 cites W2807515458 @default.
• W4384296306 cites W2900914266 @default.
• W4384296306 cites W2922119358 @default.
• W4384296306 cites W2949195531 @default.
• W4384296306 cites W3040339736 @default.
• W4384296306 cites W3096366497 @default.
• W4384296306 cites W3160437936 @default.
• W4384296306 cites W3197937320 @default.
• W4384296306 cites W4205814721 @default.
• W4384296306 cites W4210255438 @default.
• W4384296306 cites W4241770337 @default.
• W4384296306 cites W4282827611 @default.
• W4384296306 cites W4296002818 @default.
• W4384296306 cites W4307373387 @default.
• W4384296306 cites W4310956261 @default.
• W4384296306 doi "https://doi.org/10.3389/fneur.2023.1177479" @default.
• W4384296306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37521280" @default.
• W4384296306 hasPublicationYear "2023" @default.
• W4384296306 type Work @default.
• W4384296306 citedByCount "0" @default.
• W4384296306 crossrefType "journal-article" @default.
• W4384296306 hasAuthorship W4384296306A5007277206 @default.
• W4384296306 hasAuthorship W4384296306A5015560996 @default.
• W4384296306 hasAuthorship W4384296306A5017582962 @default.
• W4384296306 hasAuthorship W4384296306A5024027469 @default.
• W4384296306 hasAuthorship W4384296306A5033229269 @default.
• W4384296306 hasAuthorship W4384296306A5037045116 @default.
• W4384296306 hasAuthorship W4384296306A5040166982 @default.
• W4384296306 hasAuthorship W4384296306A5040171201 @default.
• W4384296306 hasAuthorship W4384296306A5047283512 @default.
• W4384296306 hasAuthorship W4384296306A5064840609 @default.
• W4384296306 hasAuthorship W4384296306A5069425289 @default.
• W4384296306 hasAuthorship W4384296306A5076799260 @default.
• W4384296306 hasAuthorship W4384296306A5081754547 @default.
• W4384296306 hasBestOaLocation W43842963061 @default.
• W4384296306 hasConcept C118552586 @default.
• W4384296306 hasConcept C126322002 @default.
• W4384296306 hasConcept C126838900 @default.
• W4384296306 hasConcept C143409427 @default.
• W4384296306 hasConcept C146638467 @default.
• W4384296306 hasConcept C151956035 @default.
• W4384296306 hasConcept C156957248 @default.
• W4384296306 hasConcept C16568411 @default.
• W4384296306 hasConcept C2779134260 @default.
• W4384296306 hasConcept C71924100 @default.
• W4384296306 hasConcept C90924648 @default.
• W4384296306 hasConceptScore W4384296306C118552586 @default.

• next